Pharmafile Logo
Pharmafocus logo
Advanced Search
Blog footer

Digital Pharma: UK election check-up

April 26, 2010
Medical Communications NHS, digi game, election, general election

A new lighthearted game from The Kings Fund aims to educate players on the three main political parties’ health and …

News

Nycomed partners with Merck on Daxas

April 26, 2010
Sales and Marketing Daxas, Merck & Co, Nycomed

Swiss firm Nycomed and Merck & Co have agreed to co-promote oral chronic obstructive pulmonary disease candidate Daxas in Europe. …

News

Recovery signs, but outsourcing gets more competitive

April 26, 2010
Manufacturing and Production, Research and Development Interphex, contract manufacturing, contract research, contract research organisation

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …

News

New manufacturing products launched at Interphex

April 26, 2010
Manufacturing and Production Interphex, manufacturing and production, manufacturing equipment

The annual Interphex exhibition in New York was somewhat low-key this year with attendance disrupted by the block on flights …

News
Paula Staples

Paula Staples joins Owen Mumford

April 23, 2010
Manufacturing and Production Owen Mumford, appointment, manufacturing and production

UK medical device manufacturer Owen Mumford has appointed Paula Staples as global head of quality.She joins from pharma company Abbott, …

Appointment

Parties debate future of NHS

April 22, 2010
Sales and Marketing NHS, general election

The UK general election debates turned to health policy on Thursday, with the Lib Democrats, Conservatives and Labour outlining their …

News
Digital Pharma Guide footer

Digital marketing – can we talk?

April 22, 2010
Medical Communications digital pharma, social media

The internet and online developments such as YouTube, Twitter, Wikipedia and Facebook have already revolutionised how we communicate, and with …

Feature
Collie Turner Headshot high-res

HealthTalker appoints Collie Turner

April 22, 2010
Sales and Marketing Company news, HealthTalker, appointment, new hires, pharm marketing, sales and marketing

Collie Turner has joined US word-of-mouth marketing agency HealthTalker’s leadership team as senior director of strategic partnerships. She will focus on driving new …

Appointment
Genzyme

Genzyme fined $175m for manufacturing problems

April 22, 2010
Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …

News

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010
Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …

News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010
Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …

Appointment

Novartis shines in first quarter

April 21, 2010
Sales and Marketing 2010 financials, Alcon, Novartis

Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …

News

Astellas eyes oncology growth

April 21, 2010
Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …

News

Volcanic ash fallout hits pharma

April 21, 2010
Manufacturing and Production Clinical Supply Operations, disaster, logistics, supply chain

The headline news in the wake of the Icelandic volcano eruption has been of stranded passengers struggling to get home …

News

Secondary endpoints failure take shine off Benlysta

April 21, 2010
Sales and Marketing GSK, HGS, Lupus

GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …

News
UCF 010310

Wyeth’s Ursula Franklin joins Red Kite

April 21, 2010
Business Services, Sales and Marketing Red Kite, appointment, coaching, development, leadership, sales and marketing, strategic planning, strategy, training

Red Kite has appointed Ursula Franklin to head up its new Transformation division. She joins from Wyeth Europa, now part …

Appointment

GSK’s Arzerra conditionally approved in Europe

April 20, 2010
Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010
Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …

News

Emerging markets and generics poised to drive pharma growth

April 20, 2010
Sales and Marketing IMS, em, emerging markets

The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …

News

Lilly faces substantial costs from US health reform

April 20, 2010
Sales and Marketing 2010 financials, Obama, lilly

Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026